The UFC’s drug testing partner, Combat Sports Anti-Doping (CSAD), announced on Friday that Silva tested positive for 3a-Hydroxy-2a-methyl-5a-androstan-17-one — a metabolite of drostanolone — in an out-of-competition sample he provided to Drug Free Sport International (DFSI) on April 11, 2024. “Blindado” also provided negative samples before being informed of the failure on March 30 (the date of his last fight), April 30 and June 14.
Silva’s positive sample also had extremely low levels of the banned substances, which led CSAD to conclude that the Brazilian did not inject drostanolone and was likely exposed to contamination. That combined with Silva’s co-operation during the entire process led to his anti-doping violation being deemed “likely unintentional.”
While this is Silva’s first drug violation under CSAD, he was suspended for two years…